Fight the Fat Off with APEX Profound Beauty

Food and Healthcare Press Releases Tuesday September 23, 2014 17:37
Bangkok--23 Sep--Maxima Consultants
‘Fight the Fat Off’ with APEX Profound BeautyWin Body Treatment 200,000.-Baht

To mark its 20th anniversary celebration, Apex Profound Beauty, a world class Aesthetic center for skin & body and the most advanced innovation to the best body shape organizes ‘Fight the Fat Off’ competition for public interests to deal with the weight loss for good health. The winner will get the most advanced body treatment at Apex Profound Beauty valued of 200,000.- Baht. Applicants are open during October 1- 14, 2014 at all branches Apex Profound Beauty. For more details, please contact at Tel 085-000-2001.

Overweight applicants of male and female with the average body mass index of 23 and up is being requested to enter the contest. Only 20 contestants will be selected to enter the competition and will be announced on October 15, 2014. The 20 contestants will be on body treatment with specialist doctor team at Apex for 6 weeks. The weight loss from all contestants will be accumulated for funds raising and donated to Ramathibodi Foundation, in which one kilogram is accounted for the funds of 2,000 Baht.

The winner of ‘Fight the Fat Off’ competition will receive body treatment valued of 200,000 Baht at Apex Profound Beauty and 100,000 Baht for the first runner up winner.
For more details, please call at Tel 085-000-2001.

Latest Press Release

New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care

BAVENCIO(R) (avelumab): 1451; 3152; 4174; 4256; 4823; 5113, ERBITUX(R) (cetuximab): 1212, 2589, 4455, Tepotinib (MET kinase inhibitor): 3930; 5373; 5455, M6620 (ATR inhibitor): 1547, Combinations: 4062; 4934. - New subgroup analyses for first-line...

CHMP Adopts Positive Opinion for BAVENCIO(R) (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

- Opinion based on Phase III data showing combination lowered risk of disease progression or death by 31% and improved objective response rate compared with sunitinib1 - Decision by the European Commission anticipated in fourth quarter of 2019 Merck and...

Accor Pattaya Blood Donation #3/2019

On Tuesday 17th, September 2019, Hotel Baraquda Pattaya - MGallery and Mercure Pattaya Hotel attended to Accor Pattaya Blood Donation #3/2019 at Veranda Resort Pattaya Na Jomtien - MGallery, MM Meeting Room. The event started at 10.00 a.m. to 02.00 p.m....

Tresiba(R) Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes

According to new data from the CONCLUDE head-to-head trial, Tresiba(R) (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 in...

BookDoc, partners it#s way to being Southeast Asia#s Next Generation Healthcare Ecosystem is looking to raise Series A from Strategic partners

This year crosses 100 strategic partnerships in over 20 cities across Malaysia, Singapore, Indonesia, Thailand and Hong Kong. Since commenced operations in 2015, BookDoc has grown exponentially with four consecutive years of over 450% annual growth rate...

Related Topics